Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Nucleotide Release Provides a Mechanism for Airway Surface Liquid Homeostasis
2004
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
2014 Standout
Normal and Cystic Fibrosis Airway Surface Liquid Homeostasis
2005
TEER Measurement Techniques for In Vitro Barrier Model Systems
2015 Standout
Physiological Regulation of ATP Release at the Apical Surface of Human Airway Epithelia
2006
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
2008 Standout
Identification of genes in toxicity pathways of trinucleotide-repeat RNA in C. elegans
2014 StandoutNobel
Adenosine receptors: promising targets for the development of novel therapeutics and diagnostics for asthma
2005
Introducing sense into nonsense in treatments of human genetic diseases
2008
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
2011
In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy
2002
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cystic fibrosis
2016 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
Lipid nanoparticles for mRNA delivery
2021 Standout
Nonsense-mediated decay approaches the clinic
2004
Pannexin 1 Contributes to ATP Release in Airway Epithelia
2009
Purinergic Signaling in the Airways
2012
Gold nanoparticles in delivery applications☆
2008 Standout
Aminoglycoside suppression of a premature stop mutation in a Cftr–/– mouse carrying a human CFTR-G542X transgene
2002 StandoutNobel
Genotype and Phenotype in Cystic Fibrosis
2000
Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy
2002
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Adenosine A2Breceptors are highly expressed on murine type II alveolar epithelial cells
2009
Design and development of polymers for gene delivery
2005 Standout
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
2008
A Review on the Dietary Flavonoid Kaempferol
2011 Standout
Toxicity of cationic lipids and cationic polymers in gene delivery
2006 Standout
Cystic Fibrosis
2005
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6
2001
Extracellular ATP as a signaling molecule for epithelial cells
2003
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
2017
New insights into cystic fibrosis: molecular switches that regulate CFTR
2006
Non-viral vectors for gene-based therapy
2014 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
2014
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
2017 StandoutNobel
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Processing of CFTR: Traversing the cellular maze—How much CFTR needs to go through to avoid cystic fibrosis?
2005
Nanovehicular Intracellular Delivery Systems
2008
Home management of haemophilia
2004
Some like it hot: curcumin and CFTR
2004
Effect of a Specific and Selective A2B Adenosine Receptor Antagonist on Adenosine Agonist AMP and Allergen-Induced Airway Responsiveness and Cellular Influx in a Mouse Model of Asthma
2006
Intestinal mucosal barrier function in health and disease
2009 Standout
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
2010
Regulation of Renal Organic Anion Transporter 3 (SLC22A8) Expression and Function by the Integrity of Lipid Raft Domains and their Associated Cytoskeleton
2013 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Human Airway Ecto-adenylate Kinase
2003
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Structures of membrane proteins
2010 StandoutNobel
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
Adenosine in the airways: Implications and applications
2006
Airway Mucus Function and Dysfunction
2010 Standout
Purinergic regulation of epithelial transport
2003
Metabolism of P2 Receptor Agonists in Human Airways
2004
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Barriers to Nonviral Gene Delivery
2003
Coupling of airway ciliary activity and mucin secretion to mechanical stresses by purinergic signaling
2008
Ecto 5′-Nucleotidase and Nonspecific Alkaline Phosphatase
2003
Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis
2010
Angiotensin II inhibits activity of human organic anion transporter 3 through activation of protein kinase Cα: Accelerating endocytosis of the transporter
2009
Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy
2008
An Extract from the Medicinal Plant Phyllanthus acidus and Its Isolated Compounds Induce Airway Chloride Secretion: A Potential Treatment for Cystic Fibrosis
2006
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
2002
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis andCFTRStop Mutations
2003
Correction of Nonsense BMPR2 and SMAD9 Mutations by Ataluren in Pulmonary Arterial Hypertension
2013
A Pilot Clinical Trial of Oral Sodium 4-Phenylbutyrate (Buphenyl) in Δ F508-Homozygous Cystic Fibrosis Patients
1998
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
A Pilot Study of the Effect of Gentamicin on Nasal Potential Difference Measurements in Cystic Fibrosis Patients Carrying Stop Mutations
2000
Synthetic Aminoglycosides Efficiently Suppress Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations and Are Enhanced by Ivacaftor
2013
Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution
2004
Physiology of sweat gland function: The roles of sweating and sweat composition in human health
2019 Standout
REGULATION OF NORMAL AND CYSTIC FIBROSIS AIRWAY SURFACE LIQUID VOLUME BY PHASIC SHEAR STRESS
2005
Nonviral Vectors for Gene Delivery
2008 Standout
Sweat chloride as a biomarker of CFTR activity: Proof of concept and ivacaftor clinical trial data
2013
Anilide Derivatives of an 8-Phenylxanthine Carboxylic Congener Are Highly Potent and Selective Antagonists at Human A2B Adenosine Receptors
2000
Development of cystic fibrosis and noncystic fibrosis airway cell lines
2003
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Role of CFTR in Airway Disease
1999
Inflammatory Bowel Disease
2010 Standout
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR -G542X nonsense allele in a CF mouse model
2008
Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy
2014 StandoutNobel
Receptors for Purines and Pyrimidines
2012 Standout
Ataluren as an Agent for Therapeutic Nonsense Suppression
2012
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
2001 Standout
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Guidelines for the management of hemophilia
2012 Standout
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Works of F. Ruiz being referenced
Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR.
1997
Evidence that Systemic Gentamicin Suppresses Premature Stop Mutations in Patients with Cystic Fibrosis
2001
A Clinical Inflammatory Syndrome Attributable to Aerosolized Lipid–DNA Administration in Cystic Fibrosis
2001
A2adenosine receptors regulate CFTR through PKA and PLA2
2002
Adenosine and its nucleotides activate wild-type and R117H CFTR through an A2Breceptor-coupled pathway
1999